Logo

American Heart Association

  2
  0


Final ID: MDP949

A Novel Deep Learning Approach for Prediction of Right Heart Failure After Left Ventricular Assist Device Implantation using Pulmonary Artery Pressure Tracings

Abstract Body (Do not enter title and authors here): Introduction: Left ventricular assist device (LVAD) offers a lifeline for advanced heart failure patients, but ~30% experience post-operative right heart failure (RHF) with significant morbidity and mortality. Current methods for predicting RHF risk have limited accuracy. This study is the first of its kind to explore the feasibility of using a convolutional neural network (CNN) deep learning model with pulmonary artery pressure (PAP) tracings acquired during pre-operative hemodynamic assessment to identify patients at risk for early RHF.

Methods: A CNN model was pre-trained on PAP tracings from the MIMIC-III Waveform Database to leverage transferable knowledge and improve model performance. The model learned general features and temporal relationships in hemodynamic tracing morphology for RHF prediction. It was then adapted for classification by modifying the output layers. Post-LVAD RHF was definitively adjudicated for each instance included from our 246 patient single center LVAD database. RHF was adjudicated using the 2020 Academic Research Consortium defintion. The database included 205 non-RHF instances and 41 RHF instances. We developed a novel signal processing method utilizing computer vision to extract PAP waveform data from pre-operative right heart catheterization reports. Data was reviewed to ensure accurate pressure tracing representation. SMOTE-ENN (synthetic oversampling) and class weighting addressed dataset imbalance during training to enhance model generalizability and RHF prediction accuracy.

Results: The model achieved strong performance in classifying RHF from non-RHF outcomes, as evidenced by consistent AUC scores of 0.87 and 0.85 on validation and unseen test data, respectively. These findings indicate the potential for hemodynamic tracings to predict RHF after LVAD implantation. Notably, the model maintained its performance on unseen data, highlighting its generalizability.

Conclusions: This study explored the feasibility of using a deep learning model for RHF risk stratification in patients with LVADs. The model, pre-trained on PAP tracings, achieved promising classification performance assessed by AUC. Further validation with larger, more diverse datasets will refine model performance and enhance generalizability for clinical application. Leveraging hemodynamic tracings within a deep learning framework holds promise for improved clinical outcome prediction.
  • Lamicq, Melissa  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Buchanan, Cole  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Lateef, Azalfa  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Atteya, Miriam  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Houston, Brian  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Tedford, Ryan  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Wehbe, Ramsey  ( Medical University of South Carolina , Charleston , South Carolina , United States )
  • Author Disclosures:
    Melissa Lamicq: DO NOT have relevant financial relationships | Cole Buchanan: DO NOT have relevant financial relationships | Azalfa Lateef: No Answer | Miriam Atteya: No Answer | Brian Houston: DO NOT have relevant financial relationships | Ryan Tedford: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:Merck:Active (exists now) ; Advisor:Abiomed:Active (exists now) ; Consultant:Endotronix:Active (exists now) ; Consultant:United Therapeutics:Active (exists now) ; Consultant:Restore Medical:Active (exists now) ; Consultant:Morphic Therapeutics:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Gradient:Active (exists now) ; Consultant:Edwards LifeSciences:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Alleviant:Past (completed) ; Individual Stocks/Stock Options:Aria CV:Active (exists now) ; Consultant:Acorai:Active (exists now) | Ramsey Wehbe: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Updates in Mechanical Circulatory Support

Sunday, 11/17/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
CCN2 Correlates with Early Markers of Right Ventricular Dysfunction in Adults with Pulmonary Arterial Hypertension

Schramm Jennifer, Everett Allen, Damico Rachel, Byrd Carly, Ambade Anjira, Rosen Darin, Cubero Salazar Ilton, Simpson Catherine, Tedford Ryan, Hsu Steven, Hassoun Paul

A Comparison of Outcomes in Heart Failure Patients with and without Iron Deficiency Anemia: A National Database Analysis

Bess Olva, Quevedo Ramirez Andres, Shaka Abdultawab, Oredipe Omotola, Bello Jeremiah, Shaka Hafeez

More abstracts from these authors:
Outcomes of Over 1,000 Heart Transplants Using Donation After Circulatory Death Donors in the United States

Bhandari Krishna, Tedford Ryan, Kilic Arman, Kwon Jennie, Uehara Atsuko, Sitsis Sophia, Sollie Zachary, Inampudi Chakradhari, Carnicelli Anthony, Rao Vishal N., Houston Brian

Right Atrial Pressure Respiratory Variation as a Predictor of Right Heart Failure After Left Ventricular Assist Device

Buchanan Cole, Hajj Jennifer, Wehbe Ramsey, Houston Brian, Tedford Ryan, Lamicq Melissa, Atteya Miriam, Lateef Azalfa, Read Jacob, Rao Vishal N., Friedman Samuel, Biscopink Alec, Kilic Arman

You have to be authorized to contact abstract author. Please, Login
Not Available